Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 78,450 shares at $56.94 ($4.5M) on 2025-09-08, disclosed to the SEC on 2025-09-09.
Scheduled sale ($4.5M) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.85 | 1,238 | $70K | 1.6% |
| 2 | $56.85 | 1,238 | $70K | 1.6% |
| 3 | $56.86 | 1,250 | $71K | 1.6% |
| 4 | $56.91 | 6,017 | $342K | 7.7% |
| 5 | $56.91 | 6,017 | $342K | 7.7% |
| 6 | $56.92 | 8,528 |
| $485K |
| 10.9% |
| 7 | $56.92 | 3,713 | $211K | 4.7% |
| 8 | $56.92 | 2,406 | $137K | 3.1% |
| 9 | $56.92 | 2,406 | $137K | 3.1% |
| 10 | $56.92 | 3,713 | $211K | 4.7% |
| 11 | $56.92 | 8,528 | $485K | 10.9% |
| 12 | $56.94 | 16,698 | $951K | 21.3% |
| 13 | $56.94 | 16,698 | $951K | 21.3% |
| Total | $56.92 avg | 78,450 | $4.5M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |